FDAsafety guidance66% confidence
FDA AP — TRAMADOL HYDROCHLORIDE (SUPPL)
Source: FDA
Why This Matters
Why this matters: sets a safety guidance precedent in the same sub-indication (pain) as Amneal Pharmaceuticals; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Application ANDA076003. Sponsor: AMNEAL PHARMS. Submission status: AP. Submission type: SUPPL. Active ingredients: TRAMADOL HYDROCHLORIDE.
Supporting Context
- Therapeutic area
- Neurology · Pain Management
- Sub-indication
- Pain
Related signal: FDA Grants AP Status for Milnacipran Hydrochloride by Amneal Pharmaceuticals